Arrowhead Pharmaceuticals, Inc. (ARWR)
NMS – Real Time Price. Currency in USD
78.89
-0.38 (-0.48%)
At close: Jun 26, 2026, 4:00 PM EDT
78.89
0.00 (0.00%)
After-hours: Jun 26, 2026, 5:27 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
78.89
-0.38 (-0.48%)
At close: Jun 26, 2026, 4:00 PM EDT
78.89
0.00 (0.00%)
After-hours: Jun 26, 2026, 5:27 PM EDT
No Data
There are no news for this stock.
Total debt $1.4B significantly exceeds cash reserves ($188.5M), raising financial stability concerns
Total current assets $1.8B exceed Total current liabilities $295.2M, highlighting excellent liquidity
Debt-to-equity ratio (2.3) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-5.9x) is dangerously low, suggesting debt repayment risks
The company generates positive free cash flow $81.9M, supporting its financial health
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.23 | 6.05 | 10 | |
| Quick ratio | 6.23 | 5.63 | 10 | |
| Debt to Equity | 2.24 | 0.30 | 2.0 | |
| Debt to Assets | 0.61 | 1.04 | 4.0 | |
| Interest coverage | -5.92 | -16.91 | 1.0 | |
| Weighted average score | 5.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 243M | 241M | 4M | 829M | 622M |
| Gross Profit | 233M | 228M | -15M | 806M | 597M |
| Operating Income | -179M | -205M | -601M | 98M | -222M |
| Net Income | -176M | -205M | -599M | -2M | -301M |
| EBITDA | -168M | -193M | -582M | 122M | -197M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 89.74 | 4.57 | 7.0 |
| Next quarter | -70.17 | -922.84 | 1.0 |
| Current year | -45.9 | -31093.19 | 1.0 |
| Next year | -21.09 | -24.76 | 1.0 |
| Weighted average score | 2.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -72.06 | -530.78 | -522.72 | 622.47 | 3.3 |
| Y/Y | -86.4 | -135.82 | -133.81 | -81.99 | 1.0 |
| 3y average | 7719.54 | -36.28 | -25.18 | -10.6 | 3.3 |
| 5y average | 4658.33 | -40.08 | -32.04 | -4.43 | 3.3 |
| Weighted average score | 2.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Wide | 10 |
| Intangible assets | Wide | 8.0 |
| Switching costs | Narrow | 3.0 |
| Network effect | None | 1.0 |
| Economies of scale | Narrow | 3.0 |
| Weighted average score | 5.0 | |